We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Detecto

Download Mobile App




Multi-Disease POC Breathalyzer Sniffs Out Infections and Monitors Patients on Ventilator

By HospiMedica International staff writers
Posted on 19 Jan 2023
Print article
The BREATHGUARD portable MICRO-GC medical device used to detect various biomarkers (Photo courtesy of Blu Biotech)
The BREATHGUARD portable MICRO-GC medical device used to detect various biomarkers (Photo courtesy of Blu Biotech)

A novel diagnostic testing device uses a patient's breath to diagnose various forms of cancer, COVID-19 and related variants, acute respiratory distress syndrome (ARDS), sepsis, and other acute and chronic inflammatory diseases.

Blu Biotech Inc. (Albuquerque, NM, USA) has entered into a patent license agreement with University of Michigan (U-M, Ann Arbor, MI, USA) to develop and commercialize a Micro Gas Chromatography Photoionization Detector (Micro-GC-PID) for use in diagnostic testing. The commercial device will combine high-performance breath analysis with point-of-care utilization for the diagnosis and monitoring of multiple diseases. The device separates >100 volatile chemical compounds in a breath in 10 minutes with a sub-ppb (parts-per-billion), thanks to the micro-scale components such as the microfluidic detector.

Device readings are encrypted and sent to Blu Biotech’s cloud platform where they are analyzed using the company’s proprietary algorithm. The algorithm has been developed based on machine learning and AI to analyze breath patterns revealing diseases and human health conditions. The results are finally relayed back to the device. The Micro GC device is suitable for use in hospitals and at the point-of-care to provide timely information about disease and health conditions. It can be placed at the patient’s bedside to analyze their breath every 30 minutes, similar to an electrocardiogram (ECG) that analyzes the heart condition each second. In clinical trials, the technology has demonstrated the ability to diagnose COVID-19 as well as distinguish between COVID-19 variants. The technology has also shown promise in diagnosing and monitoring of ARDS, which is the severest form of lung injury affecting over 200,000 patients a year.

"We are incredibly excited to have the opportunity to work with the University of Michigan, one of the world's leading research institutions. Together we are going to reduce cancer mortality by early and accurate cancer screening and improve the care of the critically ill and injured. Blu Biotech's expertise in biomarker development, together with University of Michigan's patented hardware, data science and clinical expertise provides for the first time a realistic point of care commercial breath test," said Robert Tavzel, Chief Executive Officer. "At Blu Biotech we continue to expand and develop breath biomarkers. Someday soon we will be able to target many other cancers, autoimmune disease, infectious disease, and even neurologic and heart diseases with the potential to save lives by early detection."

New
Platinum Supplier
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Elevating X-Ray Table
PROGNOST F
New
Vital Signs Monitor
Aurus 20 A
New
Memory Foam Mattress
MM-59

Print article

Channels

AI

view channel
Image: A novel research study moves the needle on predicting coronary artery disease (Photo courtesy of Pexels)

AI-Enabled ECG Analysis Predicts Heart Attack Risk Nearly as well as CT Scans

Increased coronary artery calcium is a marker of coronary artery disease that can lead to a heart attack. Traditionally, CT scans are used to diagnose buildup of coronary artery calcium, although CT scanners... Read more

Critical Care

view channel
Image: The new biomaterial heals tissues from the inside out (Photo courtesy of UC San Diego)

Groundbreaking Biomaterial Injected Intravenously Repairs Cells and Tissue Damaged by Heart Attack and TBI

Following a heart attack, there is development of scar tissue, which affects muscle function and can result in congestive heart failure. However, there is still no established treatment available for repairing... Read more

Surgical Techniques

view channel
Image: The neuro-chip with soft implantable electrodes could manage brain disorders (Photo courtesy of EPFL)

Implantable Neuro-Chip Uses Machine Learning Algorithm to Detect and Treat Neurological Disorders

Using a combination of low-power chip design, machine learning algorithms, and soft implantable electrodes, researchers have produced a neural interface that can identify and suppress symptoms of different... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Business

view channel
Image: The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 (Photo courtesy of Pexels)

Global Patient Positioning Systems Market Driven by Increasing Chronic Diseases

The global patient positioning systems market is projected to grow at a CAGR of 4% from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, driven by increasing technological advancements in medical devices,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.